Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.11

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (188)	4/24/1999 11:29:00 PM
From: DLJMT	Read Replies (1) of 52153

I had done a search on SI's boards when I first signed up in January and was surprised to find almost nothing on Enzon. DAK, at least now I know there's someone else here who will celebrate when Schering makes the announcement. I posted here because I was thinking of picking up some more shares in the 12-13 range and that got me thinking about IMCL, etc and how much closer to large profit Enzon was than most biotech's. I'm also learning how much more difficult it is to average up than average down but I think I can learn to like it. 50% less seems like a bargain but 6X more??? I keep trying to keep my eye on the horizon. ENZN tapped 18 when a lot of the institutional blocks were coming through and has been drifting lower slowly on decreasing volume as time goes by with no news. I'll try to get more info on what's expected & when for this thread but Begley's posts are the quickest way to get basic data. You're right... adequate cash more than cash flow. The president's message had a nice summary of all this. Lin.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next